Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Sofosbuvir / Velpatasvir / Voxilaprevir Oral Tablet [Vosevi]
DRUG
2 trials
Sponsors
Helwan University
, The Third Affiliated Hospital of Guangzhou Medical University
Conditions
Chronic Hepatitis C
Medication Reaction
Phase 4
Combined Ribavirin With Sofosbuvir/Velpatasvir/Voxilaprevir in Retreatment of Chronic Hepatitis C Non-responders
Completed
NCT04695769
Helwan University
Chronic Hepatitis C
Start: 2020-11-21
End: 2021-10-21
Updated: 2022-09-02
Unknown Phase
The Efficacy of Vosevi in Treating DAA-experienced Patients
Recruiting
NCT06180590
The Third Affiliated Hospital of Guangzhou Medical University
Chronic Hepatitis C, Medication Reaction
Start: 2023-02-28
End: 2027-02-28
Target: 200
Updated: 2024-03-13
Related Papers
A randomized-controlled trial of SOF/VEL/VOX with or without ribavirin for retreatment of chronic hepatitis C.
2023-04-23
9 citations